SCHEMBL23488152

SCHEMBL23488152

Cc1ccc(OCc2ccccc2)cc1C(=O)OC[C@H]1OC(C)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.44
MEN1 O00255 1/20 0.43
HSP90AA1 P07900 1/20 0.43
KMT2A Q03164 1/20 0.43
NMT1 P30419 4/20 0.41
NMT2 O60551 1/20 0.41
S1PR1 P21453 1/20 0.39
S1PR5 Q9H228 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
CASP3 P42574 2/20 0.39
SENP8 Q96LD8 2/20 0.39
SENP7 Q9BQF6 2/20 0.39
SENP6 Q9GZR1 2/20 0.39
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488593 1.00 MAOB (0.44) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488622 0.92 MAOB (0.44) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488472 0.88 MAOB (0.43) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488604 0.84 CHRNB2 (0.53) MAOBMEN1KMT2AL3MBTL1NPC1
SCHEMBL23488173 0.84 CHRNB2 (0.53) MAOBMEN1KMT2AL3MBTL1NPC1
SCHEMBL23488592 0.84 MAOB (0.44) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488498 0.84 MAOB (0.52) MAOBMEN1KMT2ANR1H4CHRNB2
SCHEMBL23488256 0.84 MAOB (0.41) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488257 0.83 MAOB (0.40) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488439 0.82 MEN1 (0.40) MAOBMEN1KMT2AMAOARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MAOB 4123/4885MEN1 1749/4885HSP90AA1 899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.